On LINC 2016, Dr. Teichgraber presented the results of the study using Angiodroid along with the new acquisition and post processing protocol developed by Siemens, the Even Flow CO2 Protocol.
The results were very bright and promising!
We want especially to thank Dr. Teichgraber for having conducted a highly future-oriented study of CO2 angiography and for the patients benefit.
26-29 February 2020 - booth n.J1
We are sorry, you can access this content only if you are an Healthcare Professionist. Angiodroid adopted this restriction in accordance with the Italian regulation on medical devies sponsorship (art. 21 of D.L. 24.02.97, n.46; 93/42/CEE directive; guidelines 17.02.2010)